Biologic Response Modifiers are the substances that modulate the immune response by either increasing or decreasing the immunogenic effect. These are used in immunotherapy or biological therapy for enhancing the activity of immune system to fight infection and disease. These substances are naturally produced in small amounts in the body but some of them such as interleukins, monoclonal antibodies, interferons and colony stimulating factors are now being manufactured in large units by the pharmaceutical industries.
Depending on the disease type, synthetic Biologic Response Modifiers mimics the natural cytokines or inhibitors against a receptor and thus been used in the treatment to restore, boost or dampen the host immune response. Various research studies has increased the knowledge regarding the biological agents and the effective targets are being identified.
Increasing prevalence of cancer and autoimmune diseases worldwide and upsurge in the success rates of immunotherapy treatment is going to increase the demand of Biologic Response Modifiers. Recently in 2015, a Biologic Response Modifiers Taltz (ixekizumab) is launched by Eli Lilly in Europe which made $261m in 2015.
Biologic Response Modifiers Market is likely to proliferate in the future as per current trends of increase in the number of cancer patients and autoimmune disorder cases across the globe. Immunotherapy is considered an effective treatment for patients with different types of cancer that are resistant to chemotherapy and radiation therapy treatment.
Some of the side effects such as increased risk of certain serious and opportunistic infections for patients receiving these Biologic Response Modifiers therapeutic agents, especially the risks of Tuberculosis and viral infections restraints their market to grow. Some regulatory issues related to the manufacturing and export also limits the market to expand worldwide.
High costs of biologics restricts its availability to all the section of population. Rituxan is one of the FDA approved Biologic Response Modifier drug having an average monthly cash price of more than $5000.
Biologic Response Modifiers have become an important component for the effective management of patients with a variety of autoimmune/inflammatory conditions and cancer. It reduces the side-effects of various cancer treatments, which is favored by patients. Market for Biologic Response Modifiers has increased since the last decade with dozens of drugs been approved by FDA and several research studies in this area.
Not only was biologic utilization growing, but the drug prices were also rising fast with a trend of more than 45%. Hefty prices and the increasing demand generated huge revenues for biopharmaceutical companies. The last decade has witnessed the development of various Biologic Response Modifiers, such as mABs, IFNs, TNF, ILs, CSFs, and antitumor vaccines but still there are many more opportunities to be explored. Increase in the clinical trials also expect more drugs in pipeline and thus the market will proliferate.
Geographically, North America dominates the market, followed by Western Europe and Asia Pacific. Presence of large number of biological drug and vaccine manufacturers, high per capita income, affordable treatment facility and good reimbursement scenario for life-threatening diseases proliferates the growth in North America and Western Europe segment.
NIH estimates up to 23.5 million Americans have an Auto Immune Disease and cancer affects up to 9 million Americans. Western Europe is the second largest market from both the demand side and supply side scenario. Asia pacific is expected to grow at a highest rate due to increasing prevalence of cancer patient, improvement in the healthcare facilities, more establishment of pharmaceutical companies and growing number of insurance coverage. In Asia-Pacific, China has marketed the presence of large number of patients with autoimmune disorder.
Some of the global key players in the market includes AbbVie Inc., Swedish Orphan Biovitrum, Amgen, Bristol-Myers Squibb, Novartis, Janssen Inc., Roche Holding AG, Merck & Co., Eli Lilly &Co., Biogen and many others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Segmentation by Product Type
Segmentation by Treatment Type
Segmentation by Distribution Channels
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Biological Indicator Vial Market Size and Share Forecast Outlook 2025 to 2035
Biologics Contract Manufacturing Market Size and Share Forecast Outlook 2025 to 2035
Biologics Market Analysis - Growth & Forecast 2025 to 2035
Biological and Chemical Indicators Market Insights - Trends, Growth & Forecast 2025 to 2035
Breaking Down Market Share in Biological Indicator Vial Industry
Competitive Overview of Biologics Regulatory Affairs Market Share
Biologic Excipient Market Report – Trends, Growth & Future Outlook 2024-2034
Middle East & Africa (MEA) Biologics and Biosimilar Market Analysis by Drug, Drug Class, Dosage Form, Indication, Distribution Channel, and Country through 2035
Orthobiologics Market is segmented by Product Type and End User from 2025 to 2035
Microbiological Water Testing Services Market – Growth, Demand & Safety Trends
Spine Biologics Market Size and Share Forecast Outlook 2025 to 2035
Cancer Biological Therapy Market Size and Share Forecast Outlook 2025 to 2035
Retinal Biologics Market Size and Share Forecast Outlook 2025 to 2035
Inhalable Biologics Market Analysis - Size, Share, & Forecast Outlook 2025 to 2035
Veterinary Biologics Market - Size, Share, and Forecast 2025-2035
Veterinary Biologicals Biobank Market
Global Respiratory Biologics Market Analysis – Size, Share & Forecast 2024-2034
Regenerative Biologic Injectables Market Size and Share Forecast and Outlook 2025 to 2035
Subcutaneous Biologics Market
Biosimilar and Biologics Market Analysis – Size, Share, and Forecast Outlook 2025 to 2035
Biologic Response Modifiers Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
